Thalidomide (Thalomid, Celgene) as a treatment for multiple myeloma
Approvable designations
Fast-track designations
Orphan drug designations
Recommendations against approval
FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades
June 13th 2025The FDA has accepted a New Drug Application for zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea, offering a potential new option amid rising antibiotic resistance.
Read More